Bank of New York Mellon’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-396,047
| Closed | -$11.6M | – | 4447 |
|
|
2017
Q3 | $11.6M | Sell |
396,047
-1,222
| -0.3% | -$34.2K | ﹤0.01% | 1918 |
|
|
2017
Q2 | $10.4M | Sell |
397,269
-7,739
| -2% | -$190K | ﹤0.01% | 1942 |
|
|
2017
Q1 | $9.48M | Sell |
405,008
-154,241
| -28% | -$3.81M | ﹤0.01% | 2001 |
|
|
2016
Q4 | $14.1M | Buy |
559,249
+40,934
| +8% | +$1.03M | ﹤0.01% | 1767 |
|
|
2016
Q3 | $14.5M | Sell |
518,315
-12,204
| -2% | -$313K | ﹤0.01% | 1653 |
|
|
2016
Q2 | $13.1M | Sell |
530,519
-80,472
| -13% | -$2M | ﹤0.01% | 1700 |
|
|
2016
Q1 | $13.5M | Buy |
610,991
+225,259
| +58% | +$5.99M | ﹤0.01% | 1657 |
|
|
2015
Q4 | $13.5M | Sell |
385,732
-10,287
| -3% | -$322K | ﹤0.01% | 1661 |
|
|
2015
Q3 | $11.3M | Buy |
396,019
+49,570
| +14% | +$1.67M | ﹤0.01% | 1794 |
|
|
2015
Q2 | $11.5M | Sell |
346,449
-17,815
| -5% | -$547K | ﹤0.01% | 1885 |
|
|
2015
Q1 | $10.3M | Sell |
364,264
-201,204
| -36% | -$5M | ﹤0.01% | 1942 |
|
|
2014
Q4 | $11.7M | Sell |
565,468
-30,360
| -5% | -$721K | ﹤0.01% | 1824 |
|
|
2014
Q3 | $14.6M | Sell |
595,828
-68,855
| -10% | -$1.83M | ﹤0.01% | 1657 |
|
|
2014
Q2 | $19M | Sell |
664,683
-58,063
| -8% | -$1.61M | 0.01% | 1507 |
|
|
2014
Q1 | $20.2M | Sell |
722,746
-97,652
| -12% | -$2.4M | 0.01% | 1444 |
|
|
2013
Q4 | $17.6M | Sell |
820,398
-16,265
| -2% | -$296K | ﹤0.01% | 1543 |
|
|
2013
Q3 | $11.1M | Buy |
836,663
+39,858
| +5% | +$537K | ﹤0.01% | 1776 |
|
|
2013
Q2 | $11M | Buy |
+796,805
| New | +$11.3M | ﹤0.01% | 1729 |
|
Bank of New York Mellon's PMC Position: Q4 2017 in Review
Bank of New York Mellon sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 396,047 shares — an estimated $11.6M sold.
Bank of New York Mellon first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $20.2M in Q1 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Bank of New York Mellon reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Bank of New York Mellon sold 396,047 PharMerica Corporation shares in Q4 2017, an estimated $11.6M.
- Bank of New York Mellon first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Bank of New York Mellon's PharMerica Corporation position peaked at $20.2M in Q1 2014.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Bank of New York Mellon's 13F filing for Q4 2017, filed 9 Feb 2018.